Jin David 4
4 · Fortress Biotech, Inc. · Filed Feb 14, 2023
Insider Transaction Report
Form 4
Jin David
Chief Financial Officer
Transactions
- Purchase
COMMON STOCK, PAR VALUE $0.001
2023-02-10$0.83/sh+35,928$30,000→ 1,438,757 total
Footnotes (1)
- [F1]The total holdings include 1,350,000 shares underlying deferred restricted stock units.